Correlation Between RenovoRx and Moleculin Biotech
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Moleculin Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Moleculin Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Moleculin Biotech, you can compare the effects of market volatilities on RenovoRx and Moleculin Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Moleculin Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Moleculin Biotech.
Diversification Opportunities for RenovoRx and Moleculin Biotech
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between RenovoRx and Moleculin is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Moleculin Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Moleculin Biotech and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Moleculin Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Moleculin Biotech has no effect on the direction of RenovoRx i.e., RenovoRx and Moleculin Biotech go up and down completely randomly.
Pair Corralation between RenovoRx and Moleculin Biotech
Given the investment horizon of 90 days RenovoRx is expected to generate 1.33 times more return on investment than Moleculin Biotech. However, RenovoRx is 1.33 times more volatile than Moleculin Biotech. It trades about 0.02 of its potential returns per unit of risk. Moleculin Biotech is currently generating about -0.04 per unit of risk. If you would invest 210.00 in RenovoRx on September 4, 2024 and sell it today you would lose (90.00) from holding RenovoRx or give up 42.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Moleculin Biotech
Performance |
| Timeline |
| RenovoRx |
| Moleculin Biotech |
RenovoRx and Moleculin Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Moleculin Biotech
The main advantage of trading using opposite RenovoRx and Moleculin Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Moleculin Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Moleculin Biotech will offset losses from the drop in Moleculin Biotech's long position.| RenovoRx vs. Candel Therapeutics | RenovoRx vs. Cingulate Warrants | RenovoRx vs. Unicycive Therapeutics | RenovoRx vs. Cardio Diagnostics Holdings |
| Moleculin Biotech vs. Pulmatrix | Moleculin Biotech vs. Cyclacel Pharmaceuticals | Moleculin Biotech vs. Akari Therapeutics PLC | Moleculin Biotech vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |